• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Microbiol Infect . Host immune responses and possible therapeutic targets for viral respiratory tract infections in susceptible populations: a

tetano

Editor, Senior Moderator
Clin Microbiol Infect


. 2022 Mar 17;S1198-743X(22)00149-5.
doi: 10.1016/j.cmi.2022.03.010. Online ahead of print.
Host immune responses and possible therapeutic targets for viral respiratory tract infections in susceptible populations: a narrative review


Paraskevi C Fragkou[SUP] 1 [/SUP], Charalampos D Moschopoulos[SUP] 2 [/SUP], Rieke Reiter[SUP] 3 [/SUP], Thilo Berger[SUP] 3 [/SUP], Chrysanthi Skevaki[SUP] 4 [/SUP]



Affiliations

Abstract

Background: Respiratory viruses are associated with significant global morbidity and mortality, as well as socioeconomic factors. Certain conditions and patient groups are more susceptible to develop severe viral respiratory tract infections (RTIs).
Objectives: To summarise the data on deregulated immune pathways that have been associated with increased susceptibility to severe viral RTIs in certain populations. We also describe the commonalities of the defective immune pathways across these susceptible populations that may represent possible targets for future therapeutic or preventative approaches.
Sources: We conducted free searches in Medline, Scopus and Google Scholar, for studies focusing on potential mechanisms of immune dysfunction which may be associated with severe viral RTIs in susceptible populations with conditions including pregnancy, obesity, diabetes mellitus, hypertension, cardiovascular disease, asthma, chronic obstructive pulmonary disease (COPD), chronic kidney disease and extremes of age. We considered preclinical/animal data, original human studies and reviews.
Content: Innate and adaptive immune responses become quantitatively and qualitatively compromised in aging, obesity and diabetes mellitus, with the most pronounced changes affecting T cells. Moreover, immune dysregulation by the so-called inflamm-aging results in chronic low-grade inflammation in such conditions. Increased leptin levels affect the immune system particularly in obesity, while leptin dysregulation plays a role in asthma and COPD pathogenesis. Deficient production of interferon (IFN) type I and III in response to rhinovirus contributes to asthma exacerbations. Similar attenuation of IFN production in response to influenza and rhinovirus has been documented in pregnancy. Dampened type I IFN responses have also been found in diet-induced obese mice and in obese individuals.
Implications: Immunosenescence and chronic low-grade inflammation accompanying aging and a variety of chronic conditions, such as diabetes, obesity, asthma, COPD, chronic renal disease and hypertension, contribute to the poor outcomes observed following viral respiratory infections. Commonly affected pathways may represent potential future therapeutic targets.

Keywords: Asthma; COPD; Coronary artery disease; Hypertension; chronic disease; chronic kidney disease; diabetes; obesity; pregnancy; respiratory virus.
 
Back
Top